|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
25.340 -0.100 (-0.393%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (22,742) | (298,124) | (567,843) | (898,475) | (540,486) |
| Net Cash from / (used in) Investing Activities | 2,621 | (47,604) | (58,385) | (267,825) | (396,575) |
| Net Cash from / (used in) Financing Activities | 49,725 | 449,962 | 385,676 | (27,946) | 1,392,245 |
| Increase / (Decrease) in Cash & Cash Equivalents | 29,604 | 104,234 | (240,552) | (1,194,246) | 455,184 |
| Cash & Cash Equivalents at beginning of period | 612,230 | 507,711 | 747,962 | 1,940,825 | 1,497,326 |
| Effect of Foreign Exchange Rate Changes | (5,517) | 285 | 301 | 1,383 | (11,685) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 636,317 | 612,230 | 507,711 | 747,962 | 1,940,825 |
| Remarks: | Real time quote last updated: 29/05/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -249,660 |
| %Change | -61.137% |
| EPS / (LPS) | RMB -0.240 |
| NBV Per Share (¥) | RMB 0.398 |